Philippines - anglais - FDA (Food And Drug Administration)

ambica international corp.; distributor: gx laboratories, inc. - biphasic isophane insulin human (recombinant dna origin) - suspension for injection (sc) (30% regular insulin human/70% isophane insulin human) - 100iu/ml

Philippines - anglais - FDA (Food And Drug Administration)

ambica international corp.; distributor: the cathay yss distributors co., ltd. - biphasic isophane insulin human (recombinant dna origin) - suspension for injection (sc) (30% regular insulin human/70% isophane insulin human) - 100iu/ml

Philippines - anglais - FDA (Food And Drug Administration)

team excel distribution inc.; distributor: team excel distribution inc. - neutral insulin human , isophane insulin human, recombinant dna - sterile suspension for injection ( sc ) - 100 units/ml ( 30% as neutral insulin human/ 70% as isophane insulin human )

Philippines - anglais - FDA (Food And Drug Administration)

ambica international corporation; distributor: ambicare pharmaceuticals inc. - biphasic isophane insulin human (recombinant dna origin) - suspension for injection (sc) (30% regular insulin human/70% isophane insulin human) - 100 iu/ml

Philippines - anglais - FDA (Food And Drug Administration)

sahar int'l trading inc - isophane insuline human (recombinant dna) - suspension for injection im/sc - 100 iu/ml

Irlande - anglais - HPRA (Health Products Regulatory Authority)

eli lilly nederland b.v. - human insulin (recombinant dna origin) - suspension for injection - 100 international unit(s)/millilitre - insulins and analogues for injection, intermediate-acting; insulin (human)

Irlande - anglais - HPRA (Health Products Regulatory Authority)

eli lilly nederland b.v. - human insulin (recombinant dna origin) - suspension for injection in cartridge - 100 international unit(s)/millilitre - insulins and analogues for injection, intermediate-acting; insulin (human)

Irlande - anglais - HPRA (Health Products Regulatory Authority)

eli lilly nederland b.v. - human insulin (recombinant dna origin) - suspension for injection - 100 international unit(s)/millilitre - insulins and analogues for injection, intermediate-acting; insulin (human)

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - insulin, human, recombinant dna origin 100 [iu] (as 70% isophane insulin and 30% regular insulin) - suspension for injection - 100 iu/ml - active: insulin, human, recombinant dna origin 100 [iu] (as 70% isophane insulin and 30% regular insulin) excipient: dibasic sodium phosphate heptahydrate glycerol hydrochloric acid as 10% solution for ph adjustment metacresol phenol protamine sulfate sodium hydroxide as 10% solution for ph adjustment water for injection zinc oxide - humulin is indicated for the treatment of insulin-requiring diabetes mellitus

Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - insulin, human, recombinant dna origin 100 [iu] - suspension for injection - 100 iu/ml - active: insulin, human, recombinant dna origin 100 [iu] excipient: dibasic sodium phosphate heptahydrate glycerol hydrochloric acid as 10% solution for ph adjustment metacresol phenol protamine sulfate sodium hydroxide as 10% solution for ph adjustment water for injection zinc oxide - humulin is indicated for the treatment of insulin-requiring diabetes mellitus